Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785029 · ClinicalTrials.gov registry record
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
A clinical trial, sponsored by Heidelberg Engineering.
- Terminated
- Registry status
- 234
- Enrollment target
NCT02785029 is a clinical trial that was terminated before completion, run by Heidelberg Engineering. The registered enrollment target is 234 participants.
The verdict
NCT02785029 was terminated before completion, sponsored by Heidelberg Engineering.
- TERMINATED
- Registry status
- 234 participants
- Enrollment target
Study Summary
This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in African-American descent volunteers. The main goal of the study is to provide the range of these structural parameters in normal eyes.
Interventions
- DEVICE OCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2016-06 |
| Est. Completion | 2023-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02785029
The ClinicalTrials.gov registry entry for NCT02785029 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OCT is the first listed.
NCT02785029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02785029 about?
NCT02785029 is a clinical study titled "Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)". This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in African-American descent volunteers. The...
What is the current status of trial NCT02785029?
This trial is currently terminated. The enrollment target is 234 participants. The study started on 2016-06. Estimated completion is 2023-07.
What interventions are being tested in trial NCT02785029?
The interventions under investigation include: OCT (DEVICE).
Who is sponsoring clinical trial NCT02785029?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.